Hepatitis B virus infection and the immune response: The big questions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Fattovich, 2008, Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors, J Hepatol, 48, 335, 10.1016/j.jhep.2007.11.011
Cheng, 2005, Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1, J Hepatol, 43, 465, 10.1016/j.jhep.2005.02.033
Komiya, 2008, Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C, Transfusion, 48, 286, 10.1111/j.1537-2995.2007.01522.x
Yan, 2012, Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus, Elife, 1, e00049, 10.7554/eLife.00049
Werle-Lapostolle, 2004, Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy, Gastroenterology, 126, 1750, 10.1053/j.gastro.2004.03.018
Sato, 2015, The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus, Immunity, 42, 123, 10.1016/j.immuni.2014.12.016
Dunn, 2009, Temporal analysis of early immune responses in patients with acute hepatitis B virus infection, Gastroenterology, 137, 1289, 10.1053/j.gastro.2009.06.054
Guo, 2004, Mechanism of the interferon alpha response against hepatitis C virus replicons, Virology, 325, 71, 10.1016/j.virol.2004.04.031
Seeger, 2000, Hepatitis B virus biology, Microbiol Mol Biol Rev, 64, 51, 10.1128/MMBR.64.1.51-68.2000
Wieland, 2004, Genomic analysis of the host response to hepatitis B virus infection, Proc Natl Acad Sci USA, 101, 6669, 10.1073/pnas.0401771101
Lebosse, 2017, Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B patients, J Hepatol, 66, 897, 10.1016/j.jhep.2016.12.024
Vanwolleghem, 2015, Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells, Hepatology, 62, 87, 10.1002/hep.27805
Lucifora, 2014, Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA, Science, 343, 1221, 10.1126/science.1243462
Lan, 2016, Impact of HBeAg on the maturation and function of dendritic cells, Int J Infect Dis, 46, 42, 10.1016/j.ijid.2016.03.024
Beckebaum, 2002, Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection, Clin Immunol, 104, 138, 10.1006/clim.2002.5245
van der Molen, 2004, Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B, Hepatology, 40, 738, 10.1002/hep.20366
Tavakoli, 2008, Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection, Clin Exp Immunol, 151, 61, 10.1111/j.1365-2249.2007.03547.x
Martinet, 2012, Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection, Gastroenterology, 143, 10.1053/j.gastro.2012.08.046
Woltman, 2011, Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function, PLoS One, 6, e15324, 10.1371/journal.pone.0015324
Yamamoto, 2008, Macrophage colony-stimulating factor is indispensable for repopulation and differentiation of Kupffer cells but not for splenic red pulp macrophages in osteopetrotic (op/op) mice after macrophage depletion, Cell Tissue Res, 332, 245, 10.1007/s00441-008-0586-8
Boltjes, 2015, Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function, J Infect Dis, 211, 1268, 10.1093/infdis/jiu599
Wu, 2009, Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells, Hepatology, 49, 1132, 10.1002/hep.22751
Visvanathan, 2007, Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein, Hepatology, 45, 102, 10.1002/hep.21482
Li, 2012, Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-beta1 over pro-inflammatory cytokines, Dig Liver Dis, 44, 328, 10.1016/j.dld.2011.11.005
Tu, 2008, TLR-dependent cross talk between human Kupffer cells and NK cells, J Exp Med, 205, 233, 10.1084/jem.20072195
Zhang, 2011, Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients, Hepatology, 53, 73, 10.1002/hep.23977
Zhao, 2012, Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients, PLoS One, 7, e49135, 10.1371/journal.pone.0049135
Peppa, 2010, Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection, PLoS Pathog, 6, e1001227, 10.1371/journal.ppat.1001227
Lunemann, 2014, Compromised function of natural killer cells in acute and chronic viral hepatitis, J Infect Dis, 209, 1362, 10.1093/infdis/jit561
Phillips, 2010, CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions, J Immunol, 184, 287, 10.4049/jimmunol.0902761
Zheng, 2016, NK cells help induce anti-hepatitis B virus CD8+ T cell immunity in mice, J Immunol, 196, 4122, 10.4049/jimmunol.1500846
Kimura, 2002, Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice, J Virol, 76, 10702, 10.1128/JVI.76.21.10702-10707.2002
Kakimi, 2000, Natural killer T cell activation inhibits hepatitis B virus replication in vivo, J Exp Med, 192, 921, 10.1084/jem.192.7.921
Woltman, 2009, Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled phase I/II trial, Antivir Ther, 14, 809, 10.3851/IMP1295
Rehermann, 2015, Natural killer cells in viral hepatitis, Cell Mol Gastroenterol Hepatol, 1, 578, 10.1016/j.jcmgh.2015.09.004
de Groen, 2017, NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection, Antivir Res, 140, 18, 10.1016/j.antiviral.2017.01.007
Bonorino, 2009, Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C, J Hepatol, 51, 458, 10.1016/j.jhep.2009.05.030
Tjwa, 2016, Similar frequencies, phenotype and activation status of intrahepatic NK cells in chronic HBV patients after long-term treatment with tenofovir disoproxil fumarate (TDF), Antivir Res, 132, 70, 10.1016/j.antiviral.2016.05.016
Fasbender, 2016, Natural killer cells and liver fibrosis, Front Immunol, 7, 19, 10.3389/fimmu.2016.00019
Radaeva, 2006, Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners, Gastroenterology, 130, 435, 10.1053/j.gastro.2005.10.055
Huang, 2017, T cells infiltrating diseased liver express ligands for the NKG2D stress surveillance system, J Immunol, 198, 1172, 10.4049/jimmunol.1601313
Bertoletti, 2016, Adaptive immunity in HBV infection, J Hepatol, 64, S71, 10.1016/j.jhep.2016.01.026
Webster, 2000, Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms, Hepatology, 32, 1117, 10.1053/jhep.2000.19324
Thomas, 2016, Experimental models of hepatitis B and C – new insights and progress, Nat Rev Gastroenterol Hepatol, 13, 362, 10.1038/nrgastro.2016.37
Thimme, 2003, CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection, J Virol, 77, 68, 10.1128/JVI.77.1.68-76.2003
Asabe, 2009, The size of the viral inoculum contributes to the outcome of hepatitis B virus infection, J Virol, 83, 9652, 10.1128/JVI.00867-09
Penna, 1996, Long-lasting memory T cell responses following self-limited acute hepatitis B, J Clin Invest, 98, 1185, 10.1172/JCI118902
Mizukoshi, 2004, Cellular immune responses to the hepatitis B virus polymerase, J Immunol, 173, 5863, 10.4049/jimmunol.173.9.5863
Jung, 1991, Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus, Hepatology, 13, 637, 10.1002/hep.1840130405
Penna, 1992, Fine specificity of the human T cell response to hepatitis B virus core antigen, Arch Virol Suppl, 4, 23, 10.1007/978-3-7091-5633-9_5
Penna, 1997, Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B, Hepatology, 25, 1022, 10.1002/hep.510250438
Lokhande, 2015, Methodologies for the analysis of HCV-specific CD4(+) T cells, Front Immunol, 6, 57, 10.3389/fimmu.2015.00057
Bertoletti, 1997, Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections, Gastroenterology, 112, 193, 10.1016/S0016-5085(97)70235-X
Nitschke, 2016, CD8+ T-cell responses in hepatitis B and C: the (HLA-) A, B, and C of hepatitis B and C, Dig Dis, 34, 396, 10.1159/000444555
Guidotti, 1996, Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes, Immunity, 4, 25, 10.1016/S1074-7613(00)80295-2
Kafrouni, 2001, Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms, J Immunol, 167, 1566, 10.4049/jimmunol.167.3.1566
Maini, 2000, The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection, J Exp Med, 191, 1269, 10.1084/jem.191.8.1269
Sprengers, 2006, Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans, J Hepatol, 45, 182, 10.1016/j.jhep.2005.12.022
Sprengers, 2006, Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B, J Med Virol, 78, 561, 10.1002/jmv.20576
Webster, 2004, Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy, J Virol, 78, 5707, 10.1128/JVI.78.11.5707-5719.2004
Raziorrouh, 2010, The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function, Hepatology, 52, 1934, 10.1002/hep.23936
Schurich, 2011, Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection, Hepatology, 53, 1494, 10.1002/hep.24249
Nebbia, 2012, Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection, PLoS One, 7, e47648, 10.1371/journal.pone.0047648
Kurktschiev, 2014, Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction, J Exp Med, 211, 2047, 10.1084/jem.20131333
Lopes, 2008, Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection, J Clin Invest, 118, 1835, 10.1172/JCI33402
Peppa, 2013, Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion, J Exp Med, 210, 99, 10.1084/jem.20121172
Rehermann, 1995, Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection, J Clin Invest, 96, 1527, 10.1172/JCI118191
Kefalakes, 2015, Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure, Hepatology, 62, 47, 10.1002/hep.27771
Desmond, 2012, Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease, J Virol, 86, 1181, 10.1128/JVI.05308-11
de Niet, 2016, Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy, J Hepatol, 64, 539, 10.1016/j.jhep.2015.10.013
Boni, 2012, Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues, Gastroenterology, 143, 10.1053/j.gastro.2012.07.014
Penna, 2012, Peginterferon-alpha does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis, J Hepatol, 56, 1239, 10.1016/j.jhep.2011.12.032
Sprinzl, 2014, Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment, J Viral Hepat, 21, 633, 10.1111/jvh.12189
Manigold, 2007, T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies, Lancet Infect Dis, 7, 804, 10.1016/S1473-3099(07)70289-X
Franzese, 2005, Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection, J Virol, 79, 3322, 10.1128/JVI.79.6.3322-3328.2005
Stoop, 2005, Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection, Hepatology, 41, 771, 10.1002/hep.20649
Xu, 2006, Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B, J Immunol, 177, 739, 10.4049/jimmunol.177.1.739
Yang, 2007, Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B, Int Immunol, 19, 133, 10.1093/intimm/dxl130
Peng, 2008, Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection, Immunology, 123, 57, 10.1111/j.1365-2567.2007.02691.x
Stoop, 2008, Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients, Clin Immunol, 129, 419, 10.1016/j.clim.2008.07.029
Stephan, 1984, Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen, J Virol, 51, 420, 10.1128/JVI.51.2.420-424.1984
Paul, 2017, Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a meta-analysis, Hepatology, 10.1002/hep.29082